<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>The substance-exposed child: Clinical features and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">The substance-exposed child: Clinical features and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">The substance-exposed child: Clinical features and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephanie A Deutsch, MD, MS, FAAP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel M Lindberg, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James F Wiley, II, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 17, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H577948178"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The clinical features and diagnosis of the substance-exposed child (SEC, also called the "drug endangered child") will be discussed here.</p><p>The management of the SEC, substance use in pregnancy, infants with prenatal substance use exposure, neonatal drug withdrawal, and medical child abuse including maliciously giving medications or drugs to children to cause illness are covered separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/139858.html" rel="external">"The substance-exposed child: Management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/128152.html" rel="external">"Substance use during pregnancy: Overview of selected drugs"</a> and  <a class="medical medical_review" href="/z/d/html/4799.html" rel="external">"Substance use during pregnancy: Screening and prenatal care"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5010.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Clinical features and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5016.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Management and outcomes"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6608.html" rel="external">"Medical child abuse (Munchausen syndrome by proxy)"</a>.)</p><p></p><p class="headingAnchor" id="H4098343690"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>The "substance-exposed child" (SEC, also called the "drug endangered child") refers to infants and children harmed or at risk of harm by exposure to drugs or other substances and/or an unsafe home environment related to parent or caregiver substance use. Exposures to either licit (tobacco/nicotine, alcohol) or illicit substances (drugs used recreationally with high abuse potential, such as cocaine, heroin, cannabis in some regions) may adversely impact the health and safety of the SEC [<a href="#rid1">1,2</a>]. </p><p></p><p>Harm to the SEC may result from any one of the following [<a href="#rid1">1-12</a>] (see <a class="local">'Clinical features'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Child intoxication caused by inadvertent or intentional exposure to drugs or other substances</p><p class="bulletIndent1"><span class="glyph">●</span>Child injury:</p><p class="bulletIndent2"><span class="glyph">•</span>Burns or caustic ingestion due to exposure to hazardous chemicals used in the manufacturing of illicit drugs</p><p class="bulletIndent2"><span class="glyph">•</span>Burns or wounds due to contact with unsafe drug paraphernalia (eg, needles, razor blades, or heated cookware) and potential transmission of bloodborne pathogens such as HIV and hepatitis B and C</p><p class="bulletIndent1"><span class="glyph">●</span>Impaired parent or primary caregiver resulting in an unsafe home environment and child abuse and neglect </p><p class="bulletIndent1"><span class="glyph">●</span>Exposure to violence caused by the parent's or caregiver's possession, manufacturing, production, cultivation, or distribution of legal or illegal substances </p><p class="bulletIndent1"><span class="glyph">●</span>Forced participation in illegal or sexual activity in exchange for drugs or money to obtain drugs for the parent or primary caregiver</p><p></p><p>Caregiver substance use and drug endangerment is variably addressed in civil and/or criminal child abuse and neglect statutes across the United States. Across both national and international jurisdictions, caregiver substance use may represent neglect, child endangerment or even result in felony prosecution [<a href="#rid13">13</a>]. Examples of harmful exposures that may result in legal sanctions include [<a href="#rid13">13</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Parent or caregiver use of controlled substances that impairs their ability to adequately care for the child</p><p class="bulletIndent1"><span class="glyph">●</span>Selling, distributing, or administering drugs or alcohol to a child</p><p class="bulletIndent1"><span class="glyph">●</span>Manufacturing a controlled substance in the presence of a child or within the home in which a child lives</p><p class="bulletIndent1"><span class="glyph">●</span>Exposing a child to, or permitting a child to be present where toxic precursor chemicals or equipment for the manufacture of controlled substances are used or stored</p><p class="bulletIndent1"><span class="glyph">●</span>Exposing a child to the criminal sale or distribution of drugs</p><p class="bulletIndent1"><span class="glyph">●</span>Exposing a child to drug paraphernalia</p><p></p><p>Infants of mothers with substance use disorder are a special category of SEC whose families often warrant additional protective intervention, resources, and community-based support. The evaluation and management of these infants is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5010.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5016.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Management and outcomes"</a>.)</p><p class="headingAnchor" id="H3316133422"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Approximately one in eight children in the United States reside in households with a caregiver experiencing problematic substance use that results in impaired functioning [<a href="#rid14">14</a>]. It is therefore highly likely that healthcare professionals treating either adults or children, irrespective of medical specialty, will interact with families affected by substance use in clinical practice [<a href="#rid15">15</a>].</p><p>The substance-exposed child (SEC) has a heightened risk for serious injury and other adverse outcomes including [<a href="#rid5">5-9</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Acute poisoning, especially due to ingestion of opioids (eg, heroin, <a class="drug drug_pediatric" data-topicid="12590" href="/z/d/drug information/12590.html" rel="external">methadone</a>, <a class="drug drug_pediatric" data-topicid="12918" href="/z/d/drug information/12918.html" rel="external">buprenorphine</a>, or <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">fentanyl</a>) or methamphetamine </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute and chronic exposure to hazardous chemicals used during illegal manufacturing of drugs (eg, methamphetamine production is associated with exposure to phosphorus, lye, acids, and iodine)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Physical, sexual, or emotional child abuse</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neglect (physical, emotional, educational, and/or medical)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Impaired cognitive, social, or emotional development caused by exposure to a chaotic living environment and caregiver neglect [<a href="#rid13">13,16,17</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Disproportionate out-of-home foster care placements related to impaired parenting, placement instability, and child abuse or neglect concerns [<a href="#rid4">4,10,13,18-24</a>] </p><p></p><p>In addition, a significant proportion of child maltreatment fatalities involve a caregiver with problem substance use [<a href="#rid10">10</a>]. </p><p>While interaction with an overtly intoxicated SEC or caregiver may be obvious, asymptomatic exposure in the SEC requires a high index of clinical suspicion, especially among children undergoing evaluation for abuse or neglect [<a href="#rid18">18-20</a>]. For example, in a cross-sectional study of children evaluated for physical child abuse, occult drug exposure was detected by urine testing in up to 8 percent of individuals with intermediate to high concern for abuse [<a href="#rid18">18</a>]; detection rate may be higher among centers utilizing hair testing methodology, but interpretation of these results requires expertise [<a href="#rid19">19,25</a>]. (See <a class="local">'Toxicology testing'</a> below.) </p><p>Commonly implicated substances in the SEC include:</p><p class="bulletIndent1"><span class="glyph">●</span>Opioids (prescription medications, <a class="drug drug_pediatric" data-topicid="12590" href="/z/d/drug information/12590.html" rel="external">methadone</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">fentanyl</a> [including synthetic fentanyl], and heroin) (see  <a class="medical medical_review" href="/z/d/html/6504.html" rel="external">"Opioid intoxication in children and adolescents"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Cannabis (see  <a class="medical medical_review" href="/z/d/html/97099.html" rel="external">"Cannabis (marijuana): Acute intoxication"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Methamphetamine (see  <a class="medical medical_review" href="/z/d/html/311.html" rel="external">"Methamphetamine: Acute intoxication", section on 'Pediatric considerations'</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Cocaine (see  <a class="medical medical_review" href="/z/d/html/303.html" rel="external">"Cocaine: Acute intoxication", section on 'Pediatric considerations'</a>)</p><p></p><p>Although major poisoning with life-threatening toxicity and death from illicit drug intoxication in infants and young children is rare, asymptomatic or minor exposures are more frequently reported to regional poison control centers [<a href="#rid2">2</a>]. These findings suggest that the illicit drug exposures were likely identified due to a history of suspected exposure, concerns for caregiver substance use, or performance of drug screening during medical or social evaluation.</p><p class="headingAnchor" id="H3158629400"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Clinical features include findings of substance exposure, injuries related to an unsafe environment, and/or evidence of child abuse. </p><p class="headingAnchor" id="H1991281918"><span class="h2">Findings of substance exposure</span><span class="headingEndMark"> — </span>The presentation of a substance-exposed child (SEC) occurs on a continuum varying from physical manifestations of life-threatening intoxication to asymptomatic children with positive toxicology testing [<a href="#rid2">2,4,11,26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Poisoning </strong>–<strong> </strong>The SEC may present with signs of unintentional or malicious poisoning due to agents such as opioids (see  <a class="medical medical_review" href="/z/d/html/6504.html" rel="external">"Opioid intoxication in children and adolescents"</a>), cannabis, or methamphetamine  (<a class="graphic graphic_table graphicRef71268" href="/z/d/graphic/71268.html" rel="external">table 1</a>) (see  <a class="medical medical_review" href="/z/d/html/6496.html" rel="external">"Approach to the child with occult toxic exposure"</a>). Opioid poisonings in infants may occur in an attempt to sedate the child. (See  <a class="medical medical_review" href="/z/d/html/6608.html" rel="external">"Medical child abuse (Munchausen syndrome by proxy)", section on 'Perpetrator actions'</a>.)</p><p></p><p class="bulletIndent1">Symptoms exhibited by young children after cannabis and methamphetamine exposure may vary from classic toxidromes. For example, children exposed to concentrated forms of cannabis may present with coma and respiratory depression rather than the expected findings of mild sympathomimetic effects with vomiting, conjunctival injection, nystagmus, and/or ataxia (see  <a class="medical medical_review" href="/z/d/html/97099.html" rel="external">"Cannabis (marijuana): Acute intoxication", section on 'Children'</a>). Similarly, children with cocaine or methamphetamine poisoning may exhibit lethargy rather than agitation, although the typical sympathomimetic effects (agitation, dilated pupils, tachycardia, hypertension, diaphoresis, and seizures) still frequently occur [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/311.html" rel="external">"Methamphetamine: Acute intoxication", section on 'Pediatric considerations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hazardous chemical exposure resulting in burns, caustic ingestion, or inhalational injury </strong>– Although uncommon, hazardous chemical exposure in children has been described, typically in drug-endangered children living in houses used as clandestine methamphetamine laboratories [<a href="#rid27">27,28</a>]. Chemicals potentially used during household methamphetamine production and the range of clinical effects include [<a href="#rid27">27,29</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Caustic agents (eg, sulfuric, hydrochloric, or phosphoric acid and sodium hydroxide) – Chemical burns of the skin and eyes, caustic ingestion (see  <a class="medical medical_review" href="/z/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management"</a> and  <a class="medical medical_review" href="/z/d/html/5862.html" rel="external">"Caustic esophageal injury in children"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anhydrous ammonia – Chemical burns of the skin and eyes, cold injury; inhalation can cause laryngospasm, upper airway burns, pulmonary injury, and edema (see  <a class="medical medical_review" href="/z/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Anhydrous ammonia'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Organic solvents (eg, acetone, toluene, trichloroethane, and freon) – Agent-specific toxicities are provided in the table  (<a class="graphic graphic_table graphicRef68976" href="/z/d/graphic/68976.html" rel="external">table 2</a>) and discussed separately (see  <a class="medical medical_review" href="/z/d/html/6489.html" rel="external">"Acute hydrocarbon exposure: Clinical toxicity, evaluation, and diagnosis", section on 'Hydrocarbon inhalation'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fuels (eg, kerosene or gasoline) – Hydrocarbon pneumonitis, skin or eye burns (see  <a class="medical medical_review" href="/z/d/html/6489.html" rel="external">"Acute hydrocarbon exposure: Clinical toxicity, evaluation, and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Crystallized iodine – Caustic ingestion or inhalational lung injury</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Phosphorus – Caustic ingestion; delayed multisystem organ failure (liver, kidneys, and heart) (see  <a class="medical medical_review" href="/z/d/html/94398.html" rel="external">"Overview of rodenticide poisoning", section on 'Elemental phosphorus'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Phosphine gas (produced by combining red phosphorus with iodine) – Direct cardiac toxicity associated with refractory hypotension and cardiac arrhythmias, hemorrhagic pulmonary edema with acute respiratory distress syndrome (see  <a class="medical medical_review" href="/z/d/html/94398.html" rel="external">"Overview of rodenticide poisoning", section on 'Zinc and aluminum phosphide'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Exposure to unsafe drug paraphernalia</strong> – Skin or needlestick injuries from razor blades, syringes, or heated cookware may occur after contact with unsafe drug paraphernalia. In addition to indicating likely drug exposure and need for toxicology testing, they pose a risk of transmission for bloodborne pathogens such as HIV, hepatitis B, and hepatitis C. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impaired caregiver or evaluation after rescue from a clandestine drug laboratory (potential exposure) </strong>–<strong> </strong>In this circumstance, the SEC may be asymptomatic or minimally symptomatic but exposed. Such occult exposures require detection by toxicology testing [<a href="#rid2">2,18-20</a>]. (See <a class="local">'Toxicology testing'</a> below.)</p><p></p><p class="headingAnchor" id="H2129196673"><span class="h2">Signs of child abuse</span><span class="headingEndMark"> — </span>In addition to evidence of drug exposure, the SEC may have findings of child abuse [<a href="#rid4">4,10,13,21,22,30,31</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical child abuse</strong> – Common findings include bruises, burns, fractures, and/or other injuries that are suspicious or unexplained  (<a class="graphic graphic_table graphicRef109401" href="/z/d/graphic/109401.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef119441" href="/z/d/graphic/119441.html" rel="external">table 4</a>). (See  <a class="medical medical_review" href="/z/d/html/103420.html" rel="external">"Physical child abuse: Recognition"</a> and  <a class="medical medical_review" href="/z/d/html/6600.html" rel="external">"Physical child abuse: Diagnostic evaluation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sexual abuse</strong> – For children who are sexually abused, disclosure of sexual molestation on history is the most important finding; a normal physical examination does not exclude sexual abuse. Clinical findings are provided in the table  (<a class="graphic graphic_table graphicRef65874" href="/z/d/graphic/65874.html" rel="external">table 5</a>). In addition to sexual abuse by a caregiver or family member, the SEC may be sexually exploited to obtain money or drugs for the caregiver. Evaluation for sexual abuse is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neglect </strong>– Clinical findings of neglect may present as poor hygiene, lack of adequate clothing or diapers, signs of starvation, failure to thrive, or serious injury caused by lack of appropriate supervision or inadequate protection from drug-related violence. The child may also demonstrate impaired cognitive, social, or emotional development related to a chaotic living environment or inadequate supervision. Older children may have chronic school truancy. (See  <a class="medical medical_review" href="/z/d/html/6603.html" rel="external">"Child neglect: Evaluation and management"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emotional abuse</strong> – The SEC often lacks caregiver love and affection and is exposed to a dangerous environment with little emotional support. In addition, the child may be demeaned, criticized, threatened, or rejected by the caregiver. These experiences may manifest as withdrawal, passivity, poor social development, acting out behavior, anxiety, depression, or post-traumatic stress disorder. (See  <a class="medical medical_review" href="/z/d/html/93408.html" rel="external">"Anxiety disorders in children and adolescents: Assessment and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/1224.html" rel="external">"Pediatric unipolar depression: Epidemiology, clinical features, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/14345.html" rel="external">"Posttraumatic stress disorder in children and adolescents: Epidemiology, clinical features, assessment, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H3541532753"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of a substance-exposed child (SEC) is based on evidence of harm or risk of harm caused by drug or substance exposure due to caregiver actions such as [<a href="#rid2">2</a>]:<strong> </strong></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impaired caregiver</strong> – Interaction with, or exposure to an overtly impaired caregiver renders a child unsafe, inadequately supervised, and/or at high risk for serious illness, injury, physical harm, or clinically occult substance exposure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Poisoning or substance exposure</strong> – For the asymptomatic child found living in a home used for illicit drug manufacturing or distribution (eg, methamphetamine or synthetic <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">fentanyl</a>) or cultivation (eg, marijuana or psychedelic mushrooms), the diagnosis of SEC can be made by signs of child abuse and/or positive toxicology testing. Testing must evaluate for acute as well as chronic substance exposure, which requires enhanced, specialized urine toxicology testing and occasionally the use of hair testing. (See <a class="local">'Toxicology testing'</a> below.) </p><p></p><p class="bulletIndent1">Clinical signs, symptoms and/or positive toxicological test results consistent with poisoning or environmental exposure, including exposure to hazardous chemicals used in illicit drug manufacturing (eg, hydrocarbon pneumonitis, chemical burns, inhalational injury, or caustic ingestion) provide acute confirmation of drug or substance exposure. (See <a class="local">'Findings of substance exposure'</a> above.)</p><p></p><p class="bulletIndent1">Among symptomatic SECs, common findings of poisoning due to specific drugs  (<a class="graphic graphic_table graphicRef71268" href="/z/d/graphic/71268.html" rel="external">table 1</a>) include: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Opioid poisoning</strong>:</p><p class="bulletIndent3"><span class="glyph">-</span>Coma</p><p class="bulletIndent3"><span class="glyph">-</span>Respiratory depression progressing to apnea, bradycardia, hypotension, and hypothermia</p><p class="bulletIndent3"><span class="glyph">-</span>Miosis (often pinpoint pupils)</p><p class="bulletIndent3"><span class="glyph">-</span>Decreased muscle tone with hyporeflexia </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sympathomimetic poisoning (methamphetamine or cocaine)</strong>: </p><p class="bulletIndent3"><span class="glyph">-</span>Agitation/irritability which can progress to seizures</p><p class="bulletIndent3"><span class="glyph">-</span>Hyperthermia, tachycardia, tachypnea, and hypertension </p><p class="bulletIndent3"><span class="glyph">-</span>Dilated pupils</p><p class="bulletIndent3"><span class="glyph">-</span>Excessive sweating with cold, clammy skin</p><p class="bulletIndent3"><span class="glyph">-</span>Increased bowel sounds </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cannabis</strong> – Limited exposure (see  <a class="medical medical_review" href="/z/d/html/97099.html" rel="external">"Cannabis (marijuana): Acute intoxication", section on 'Children'</a>):</p><p class="bulletIndent3"><span class="glyph">-</span>Tachycardia with hypertension</p><p class="bulletIndent3"><span class="glyph">-</span>Conjunctival injection (red eye)</p><p class="bulletIndent3"><span class="glyph">-</span>Vomiting</p><p class="bulletIndent3"><span class="glyph">-</span>Nystagmus</p><p class="bulletIndent3"><span class="glyph">-</span>Ataxia</p><p class="bulletIndent3"><span class="glyph">-</span>Slurred speech in verbal children</p><p></p><p class="bulletIndent2">In large overdoses (eg, ingestion of edible products, concentrated oils, or hashish), coma with apnea or depressed respirations can occur. Although uncommon, seizures have been reported. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Physical injuries</strong> – Puncture wounds or other injuries (eg, lacerations or burns) caused by unrestricted access to drug paraphernalia (eg, needles or razor blades). </p><p></p><p>Children presenting for evaluation of possible substance exposure warrant careful consideration of co-existing child abuse including evaluation for physical, sexual, emotional abuse and/or neglect. (See  <a class="medical medical_review" href="/z/d/html/6600.html" rel="external">"Physical child abuse: Diagnostic evaluation and management"</a> and  <a class="medical medical_review" href="/z/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/6603.html" rel="external">"Child neglect: Evaluation and management"</a>.) </p><p>In addition, some children presenting with suspected child abuse may warrant toxicologic screening. (See  <a class="medical medical_review" href="/z/d/html/6600.html" rel="external">"Physical child abuse: Diagnostic evaluation and management", section on 'Toxicology'</a>.)</p><p class="headingAnchor" id="H2158107444"><span class="h1">DIAGNOSTIC EVALUATION</span></p><p class="headingAnchor" id="H2642611339"><span class="h2">Approach</span><span class="headingEndMark"> — </span>The evaluation of the substance-exposed child (SEC) focuses on identifying the drug or substance exposure that is endangering the child and the effects and risks from exposure. It includes all of the following [<a href="#rid1">1,4,22,32</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Thorough history and physical examination </p><p class="bulletIndent1"><span class="glyph">●</span>Assessment of family interaction</p><p class="bulletIndent1"><span class="glyph">●</span>Toxicological testing</p><p class="bulletIndent1"><span class="glyph">●</span>Diagnostic evaluation for children with signs of co-occurring abuse or neglect </p><p></p><p>Key clinical questions when evaluating the SEC include (see <a class="local">'Clinical features'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Poisoning or substance exposure</strong> – Is there history, clinical signs or symptoms or toxicological test results indicating systemic or environmental substance exposure, such as signs of poisoning or contact with harmful chemicals involved in substance manufacturing or clinically occult substance exposure? Historical information and evidence shared by child protective services, law enforcement, social work professionals, paramedics, or first responders is vital. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unsafe environment</strong> – Is there reason to suspect that safe disposition of the child cannot be assured without additional protective intervention (eg, family interaction identifies that the primary caregiver is impaired)?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Social history</strong> – Have co-occurring psychosocial adversities been identified (eg, housing or food insecurity), that warrant referral to community-based resources or other supportive services/programming?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Co-existing child abuse</strong> – Does the child exhibit any co-occurring signs of physical, sexual, emotional abuse and/or neglect that require further evaluation?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reporting</strong> – Have child safety concerns been reported to appropriate authorities, including child protective services and/or law enforcement?</p><p></p><p class="headingAnchor" id="H407656160"><span class="h2">History</span><span class="headingEndMark"> — </span>Obtaining an accurate history from a parent/primary caregiver when evaluating an SEC is often challenging: </p><p class="bulletIndent1"><span class="glyph">●</span>Caregivers may exhibit reluctance to share details of substance use (out of concerns for civil or criminal penalties) </p><p class="bulletIndent1"><span class="glyph">●</span>Caregivers may be overtly impaired or intoxicated </p><p class="bulletIndent1"><span class="glyph">●</span>Caregivers may be unavailable due to legal intervention (such as arrest) or co-occurring physical or mental health issue (resulting in hospitalization)</p><p></p><p>For this reason, historical information and evidence shared by child protective services, law enforcement, social work professionals, paramedics or first responders may be vital. Specific scene investigation (such as substance presence, paraphernalia, specific chemical precursors, poor living conditions or observation of impaired adults exhibiting particular toxidromes) can help guide toxicological testing, communicable disease assessment, and/or evaluation for co-occurring child abuse or neglect [<a href="#rid33">33</a>]. (See <a class="local">'Toxicology testing'</a> below.)</p><p>If available, recent child safety concerns (such as recent hotline reports and/or investigations regarding physical, sexual, emotional abuse and/or neglect, or prior history of prenatal substance exposure) may indicate the need for child abuse evaluation. (See  <a class="medical medical_review" href="/z/d/html/6600.html" rel="external">"Physical child abuse: Diagnostic evaluation and management"</a> and  <a class="medical medical_review" href="/z/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents"</a>.) </p><p>Review of primary care records and/or social work notes that document relevant family and social history may yield additional important information about environmental risk factors and aid in identification of siblings/household contacts who require evaluation.</p><p class="headingAnchor" id="H3475473748"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The SEC warrants a thorough physical examination<strong> </strong>with attention to the following findings [<a href="#rid4">4,11</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Evidence of neglect such as poor hygiene, inadequate clothing or diapers, malnutrition (failure to thrive), poor dentition, untreated medical condition, or injury caused by inadequate supervision (see  <a class="medical medical_review" href="/z/d/html/6603.html" rel="external">"Child neglect: Evaluation and management", section on 'Evaluation'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Red flag injuries suggesting child physical abuse  (<a class="graphic graphic_table graphicRef109402" href="/z/d/graphic/109402.html" rel="external">table 6</a>) (see  <a class="medical medical_review" href="/z/d/html/103420.html" rel="external">"Physical child abuse: Recognition"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical findings associated with sexual abuse  (<a class="graphic graphic_table graphicRef65874" href="/z/d/graphic/65874.html" rel="external">table 5</a>) (see  <a class="medical medical_review" href="/z/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical findings of sexual assault or sex trafficking  (<a class="graphic graphic_table graphicRef108340" href="/z/d/graphic/108340.html" rel="external">table 7</a>) (see  <a class="medical medical_review" href="/z/d/html/2765.html" rel="external">"Evaluation and management of adult and adolescent sexual assault victims in the emergency department"</a> and  <a class="medical medical_review" href="/z/d/html/106947.html" rel="external">"Human trafficking: Identification and evaluation in the health care setting"</a>) </p><p></p><p>The SEC may also present with physical findings of serious poisoning or injury. The table provides signs and symptoms by common toxins  (<a class="graphic graphic_table graphicRef71268" href="/z/d/graphic/71268.html" rel="external">table 1</a>). In the most serious exposures, findings may include: </p><p class="bulletIndent1"><span class="glyph">●</span>Lethargy or coma with respiratory depression suggesting opioid intoxication or marijuana intoxication (see  <a class="medical medical_review" href="/z/d/html/6504.html" rel="external">"Opioid intoxication in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/97099.html" rel="external">"Cannabis (marijuana): Acute intoxication", section on 'Children'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Agitation, seizures, tachycardia, tachypnea, hypertension, and hyperthermia pointing to sympathomimetic intoxication (eg, methamphetamine or cocaine) (see  <a class="medical medical_review" href="/z/d/html/311.html" rel="external">"Methamphetamine: Acute intoxication"</a> and  <a class="medical medical_review" href="/z/d/html/303.html" rel="external">"Cocaine: Acute intoxication"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe eye and airway irritation with tearing blepharospasm, rhinorrhea, drooling, hoarseness, stridor, wheezing, and respiratory distress due to inhalational injury from phosgene or anhydrous ammonia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chemical burns to the skin  (<a class="graphic graphic_picture graphicRef126230" href="/z/d/graphic/126230.html" rel="external">picture 1</a>) or eyes  (<a class="graphic graphic_picture graphicRef67858" href="/z/d/graphic/67858.html" rel="external">picture 2</a>), with or without signs of caustic ingestion (eg, oral burns  (<a class="graphic graphic_picture graphicRef93916" href="/z/d/graphic/93916.html" rel="external">picture 3</a>), drooling, dysphagia, or chest pain [may initially be asymptomatic]) from caustic chemical exposure (eg, sulfuric or hydrochloric acid, sodium or potassium hydroxide, or concentrated ammonia) (see  <a class="medical medical_review" href="/z/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management"</a> and  <a class="medical medical_review" href="/z/d/html/5862.html" rel="external">"Caustic esophageal injury in children"</a>)</p><p></p><p class="bulletIndent1">Of these potential exposures, ingestion of concentrated sulfuric acid by unsupervised toddlers resulting in severe burns to the perioral skin, oropharynx, upper airway, esophagus and gastrointestinal tract have been reported [<a href="#rid27">27,28</a>]. </p><p></p><p class="headingAnchor" id="H1073781301"><span class="h2">Family interaction</span><span class="headingEndMark"> — </span>Interaction with a suspected or obviously impaired caregiver may occur across a variety of scenarios, including accompaniment of the SEC to a medical appointment, such as a routine primary care appointment unrelated to abuse/neglect or SEC concerns. (See  <a class="medical medical_review" href="/z/d/html/139858.html" rel="external">"The substance-exposed child: Management", section on 'Child of an impaired caregiver'</a>.) </p><p>Screening caregivers from families known to be experiencing problem substance use for co-occurring psychosocial adversities (intimate partner violence, mental health concerns, economic insecurity) is important to facilitate appropriate linkage to community-based resources and supportive programming [<a href="#rid4">4,34-36</a>].</p><p class="headingAnchor" id="H3661562162"><span class="h2">Toxicology testing</span><span class="headingEndMark"> — </span>Toxicological testing is an essential component in the evaluation of the SEC [<a href="#rid4">4,18-20,37-40</a>]. However, healthcare professionals should not rely solely on a positive or negative toxicology test to make the diagnosis; test results should be interpreted within the broader context of home environment and the child's safety [<a href="#rid12">12,41</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications</strong> – Indications for testing include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>History or physical findings of drug or illicit substance poisoning or exposure in the child, including history obtained from objective third party observers (eg, social workers, prehospital medical personnel, and/or police)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Parent/primary caregiver impairment (directly observed by the clinician, reported by an objective observer, or suspected by history)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Concern for co-occurring physical, sexual, emotional abuse and/or neglect (see  <a class="medical medical_review" href="/z/d/html/6600.html" rel="external">"Physical child abuse: Diagnostic evaluation and management", section on 'Toxicology'</a>)</p><p></p><p class="bulletIndent1">In some jurisdictions, evidentiary toxicology testing for the SEC during medical treatment may result from legal intervention (issuance of subpoenas or law enforcement warrants) [<a href="#rid4">4,42</a>]. Complying with these requests for testing should consider whether testing is also indicated for the health and safety of the child. Although this is the case in most instances, toxicological testing for purposes other than child health and safety typically requires informed consent of the legal guardian. Obtaining testing specifically for criminal justice purposes without informed consent is problematic in many jurisdictions [<a href="#rid43">43</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chain of custody</strong> – When obtaining toxicologic testing in the SEC, it is advisable to collect and transport samples using a traceable chain of custody, including careful documentation. Laboratory results for samples for which a chain of custody is not maintained may still be used as evidence, but problems establishing validity may arise. (See  <a class="medical medical_review" href="/z/d/html/13846.html" rel="external">"Testing for drugs of abuse (DOAs)", section on 'Chain of custody for evidence'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recommended testing </strong>–<strong> </strong>Specific toxicology testing for suspected substance exposure varies based upon clinical findings and regional illicit substance use trends: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Drugs of abuse testing</strong> – Toxicology testing should be obtained in children with suspected substance exposure. Commonly available testing usually consists of urine screens for drugs of abuse. For children with a known exposure to a clandestine drug laboratory, urine should be obtained as soon as possible after the last exposure, ideally within 6 to 12 hours [<a href="#rid29">29</a>]. Substances detected, time frame for detection after acute exposure, and potential causes of false positives are summarized in the table  (<a class="graphic graphic_table graphicRef95110" href="/z/d/graphic/95110.html" rel="external">table 8</a>). </p><p></p><p class="bulletIndent2">Advantages of urine specimens include: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Ease of collection </p><p class="bulletIndent3"><span class="glyph">-</span>Prolonged duration of excreted parent substances and metabolites that permit longer detection windows compared with serum </p><p class="bulletIndent3"><span class="glyph">-</span>During use in clinical settings, greater reliability than saliva testing</p><p></p><p class="bulletIndent2">All positive results on initial drugs of abuse screens require confirmation with advanced laboratory methods (eg, gas chromatography with mass spectrophotometry [GC-MS], high performance liquid chromatography [HPLC] with MS, or HPLC with tandem MS). Interpretation of results requires specific knowledge of the assay used for toxin detection and correlation with clinical findings. Consultation with a medical toxicologist (available through a regional poison control center) is encouraged. Interpretation of drugs of abuse tests are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/13846.html" rel="external">"Testing for drugs of abuse (DOAs)"</a>.)</p><p></p><p class="bulletIndent2">Expanded ("comprehensive") drug screens are available in some institutions and can evaluate for novel synthetic analogues or over-the-counter, non-prescribed and prescribed pharmaceuticals (inappropriately used, not as directed) which frequently go undetected on standard urine drug screens. Advanced methods used for confirmation of drug screens are commonly employed by urine expanded/comprehensive drug screens. Studies suggest a combination of historical information and performance of expanded/comprehensive drug screens detect more substances than standard urine drug screens alone, including among SEC undergoing abuse evaluations and pediatric patients presenting with unknown substance ingestions [<a href="#rid38">38,44-47</a>]. When clinical suspicion of poisoning is high, the clinician should obtain and store an additional 10mL of urine to facilitate completion of expanded drug testing. While expanded/comprehensive drug screen performance can aid in additional substance detection, results may not be available for several days to weeks [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Assays for synthesized illicit drugs</strong> – It may be necessary to specifically request an assay for illicit drugs that may not be included or detected on the available screen for drugs of abuse (eg, <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">fentanyl</a>, fentanyl analogs, or synthetic cannabinoids). Illicit substance use trends in the local community are available from regional poison control centers and law enforcement. Consultation with a medical toxicologist or clinical laboratory specialist with similar expertise assists with identification of likely substances responsible for acute signs and symptoms. They can also guide appropriate testing and advise on specialized laboratories where testing for these substances can be performed. If the original product is available, it can often be examined through forensic analytic laboratories (eg, drug enforcement agencies).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hair testing</strong> – Unlike testing of urine, hair testing typically detects non-acute substance exposures (weeks to months) and are most appropriate for forensic purposes to establish remote drug exposure such as asymptomatic children suspected of substance exposure in whom more routine toxicology drug testing is negative [<a href="#rid4">4,12</a>]. Testing of hair specimens should only be performed by laboratories that routinely handle alternative specimens. Hair testing should <strong>not</strong> be used to evaluate for acute exposure or intoxication [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent2">A minimum of two inches (5 cm) of hair is typically required. When testing specifically for substance use or systemic exposure, pre-test hair washing to remove external substance residue from hair shaft surfaces is necessary. On the other hand, this step may be omitted in a separate sample to establish environmental exposures in support of drug endangerment, particularly for those cases involving substance manufacturing (eg, methamphetamine) that results in aerosolized substance residue [<a href="#rid4">4,5,48</a>]. </p><p></p><p>Toxicology testing specific to infants with prenatal substance exposure and drug-facilitated sexual assault are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5010.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2765.html" rel="external">"Evaluation and management of adult and adolescent sexual assault victims in the emergency department"</a>.) </p><p class="headingAnchor" id="H3026885225"><span class="h3">Interpretation of results</span><span class="headingEndMark"> — </span>A diagnosis of an SEC is supported by the following toxicology test results:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Illicit drug or substance exposure</strong> – Any confirmed illicit drug/substance exposure, based upon history, clinical features, and/or toxicology testing indicates an SEC.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Legal nonpharmaceutical drug or substance exposure </strong>– Certain substances that are legal for adult use (such as ethanol or, in certain jurisdictions, marijuana) nevertheless indicate substance exposure when testing confirms them as causing intoxication or exposure in young children [<a href="#rid49">49</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Certain prescription drug exposures</strong> – Exposure to prescription drugs not intended for treatment of a specific condition in the child and permitted for the child's recreational use, intentionally administered to child by the primary caregiver, or caused by lack of supervision due to primary caregiver intoxication impairment. </p><p></p><p>Careful interpretation of results considers the patient's clinical findings and detailed knowledge of the specific toxicologic testing that has been performed. Consultation with a medical toxicologist or clinical lab specialist with similar expertise is essential. Misinterpretation of toxicological test results can have serious medical consequences (eg, missed diagnosis of an SEC due to a false negative or not considering substances not tested on the assay) or social consequences, such as a child protection investigation that may lead to removal of the child from the home and arrest of the primary caregiver based upon a false positive result:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urine testing</strong> – The table provides common causes of false positive results for urine drugs of abuse screens  (<a class="graphic graphic_table graphicRef95110" href="/z/d/graphic/95110.html" rel="external">table 8</a>). The interpretation of urine drugs of abuse testing of urine is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/13846.html" rel="external">"Testing for drugs of abuse (DOAs)", section on 'Interpreting results'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hair testing</strong> – Factors like external contamination, hair structure, growth rate, melanin content and cosmetic alteration may influence results [<a href="#rid4">4,41,49,50</a>]. For asymptomatic children undergoing hair testing for forensic purposes, specimens should only be performed by experienced laboratories. A minimum of two inches (5 cm) of hair is typically required. When testing specifically for substance use or systemic exposure, pre-test hair washing to remove external substance residue from hair shaft surfaces is necessary. On the other hand, this step may be omitted in a separate sample to establish environmental exposures in support of drug endangerment, particularly for those cases involving substance manufacturing leading to aerosolized substance residue (eg, methamphetamine) [<a href="#rid4">4,5,48</a>]. </p><p></p><p class="bulletIndent1">Incorporation of substances into hair occurs by several possible routes [<a href="#rid4">4</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Systemic circulation and follicular capillary supply</p><p class="bulletIndent2"><span class="glyph">•</span>Sweat and/or sebum deposition</p><p class="bulletIndent2"><span class="glyph">•</span>Environmental, superficial external hair contamination</p><p></p><p class="bulletIndent1">Furthermore, substance incorporation into hair varies by affinity to hair melanin and lipophilicity, hair growth rates, timing relative to exposure, and performance of prewash steps. Metabolite detection may also not be indicative of systemic exposure because tissues around the hair follicle contain enzymes that may metabolize parent substances into metabolites (eg, cocaine to benzoylecgonine) when exposed to air or moisture after collection [<a href="#rid48">48</a>]. In addition, the frequency and degree of substance exposure cannot be predicted based on hair testing alone. For this reason, hair follicle testing of children is <strong>not</strong> recommended as an effective method of confirming caregiver use and impairment [<a href="#rid12">12</a>].</p><p></p><p class="headingAnchor" id="H3462990420"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>It is essential to consider substance exposure for all children who present with [<a href="#rid18">18,27,28,38,51</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Burns and/or explosive injuries from house fires</p><p class="bulletIndent1"><span class="glyph">●</span>Physical, sexual, emotional abuse or neglect</p><p class="bulletIndent1"><span class="glyph">●</span>"Unintentional poisoning" including those with exposure to chemical precursors of illicit drug manufacturing (eg, methamphetamine) (see <a class="local">'Findings of substance exposure'</a> above)</p><p></p><p>Investigation by law enforcement and fire safety officials can confirm the presence of possible clandestine drug manufacturing in the child's home. In addition, for children with suspected methamphetamine exposure, urine and hair toxicology testing for amphetamines are frequently positive. (See <a class="local">'Toxicology testing'</a> above.) </p><p>In pediatric patients undergoing toxicologic testing because of suspicion of substance exposure or impaired caregivers, substance exposure needs to be differentiated from other reasons for positive results:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>False positive results</strong> – For children with positive urine drug screens, correct interpretation relies upon confirmation with advanced laboratory methods (eg, gas chromatography with mass spectrophotometry [GC-MS], high performance liquid chromatography [HPLC] with MS, or HPLC with tandem MS) and assessment of whether the child has been exposed to substances that can cause false positive urine drug testing results  (<a class="graphic graphic_table graphicRef95110" href="/z/d/graphic/95110.html" rel="external">table 8</a>). (See  <a class="medical medical_review" href="/z/d/html/13846.html" rel="external">"Testing for drugs of abuse (DOAs)", section on 'What does a positive DOA test result mean?'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Therapeutic drug administration or use</strong> – For children or possibly impaired caregivers with true positive toxicology testing, the physician should establish whether the result is explained by therapeutic drug administration for conditions such as chronic pain or epilepsy. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recreational drug use</strong> – For adolescents with positive toxicology testing, it is important to determine if the results are due to the patient's recreational use rather than caused by the caregiver's actions. </p><p></p><p class="headingAnchor" id="H2996372027"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology </strong>– The "substance-exposed child" (SEC, also called the "drug endangered child") refers to infants and children harmed or at risk of harm by drugs or other substances and/or an unsafe home environment related to parent or caregiver substance use. (See <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features </strong>– The presentation of the SEC occurs on a continuum varying from physical manifestations of life-threatening intoxication to asymptomatic children with positive toxicology testing (see <a class="local">'Findings of substance exposure'</a> above): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Poisoning</strong> – Signs of unintentional or malicious poisoning may be caused by agents such as opioids, cannabis, or methamphetamine  (<a class="graphic graphic_table graphicRef71268" href="/z/d/graphic/71268.html" rel="external">table 1</a>). Symptoms exhibited by young children after cannabis and methamphetamine exposure may vary from classic toxidromes. For example, children exposed to concentrated forms of cannabis may present with coma and respiratory depression rather than the expected findings of mild sympathomimetic effects with vomiting, conjunctival injection, nystagmus, and/or ataxia; instead of the typical sympathomimetic effects, children with cocaine or methamphetamine poisoning may exhibit lethargy.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chemical burns, caustic ingestion, or inhalational injury</strong> – Although uncommon, hazardous chemical exposure in children has been described, typically in drug-endangered children living in houses used as clandestine methamphetamine laboratories.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Exposure to drug paraphernalia</strong> – Contact with drug paraphernalia can cause skin or needlestick injuries from razor blades or syringes. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Impaired caregiver or evaluation after rescue from a clandestine drug laboratory (potential exposure) </strong>–<strong> </strong>In this circumstance, the SEC may be asymptomatic or minimally symptomatic but exposed. Such occult exposures require detection by toxicology testing. </p><p></p><p class="bulletIndent1">In addition to evidence of substance exposure, the SEC may have findings of physical  (<a class="graphic graphic_table graphicRef109401" href="/z/d/graphic/109401.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef119441" href="/z/d/graphic/119441.html" rel="external">table 4</a>), sexual  (<a class="graphic graphic_table graphicRef65874" href="/z/d/graphic/65874.html" rel="external">table 5</a>), or emotional child abuse and/or neglect. (See <a class="local">'Signs of child abuse'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis and diagnostic evaluation </strong>– The diagnosis of an SEC is based on evidence of harm or risk of harm caused by substance exposure resulting from caregiver actions. Key findings include (see <a class="local">'Approach'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Poisoning or substance exposure</strong> – Exposures range from acute symptomatic intoxication to chronic asymptomatic or minimally symptomatic exposure to hazardous drugs and chemicals caused by the caregiver's substance use disorder or illicit drug activities. (See <a class="local">'History'</a> above and <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Co-existing child abuse</strong> – Signs include evidence of sexual abuse/assault  (<a class="graphic graphic_table graphicRef65874" href="/z/d/graphic/65874.html" rel="external">table 5</a>) or sex trafficking  (<a class="graphic graphic_table graphicRef108340" href="/z/d/graphic/108340.html" rel="external">table 7</a>), physical abuse  (<a class="graphic graphic_table graphicRef109402" href="/z/d/graphic/109402.html" rel="external">table 6</a>), emotional abuse and/or neglect. (See <a class="local">'History'</a> above and <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Unsafe environment</strong> – The child is determined to be at risk because of primary caregiver impairment and/or an unsafe home environment related to the caregiver's substance use or manufacturing. (See <a class="local">'Family interaction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Social history</strong> – The primary caregiver's substance use has led to housing or food insecurity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Toxicology testing</strong> – Although an essential component of the evaluation, healthcare professionals should <strong>not</strong> rely solely on a positive or negative toxicology test to make the diagnosis; test results should be interpreted within the broader context of home environment and the child's safety. Indications for testing include (see <a class="local">'Toxicology testing'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>History or physical findings of drug or illicit substance poisoning or exposure in the child, including history obtained from objective third party observers (eg, social workers, prehospital medical personnel, and/or police)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Parent/primary caregiver impairment (directly observed by the clinician, reported by an objective observer, or suspected by history)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Concern for co-occurring physical, sexual, emotional abuse and/or neglect (see  <a class="medical medical_review" href="/z/d/html/6600.html" rel="external">"Physical child abuse: Diagnostic evaluation and management", section on 'Toxicology'</a>)</p><p></p><p class="bulletIndent2">Specific toxicology testing varies based upon the type of suspected exposure (acute or chronic); consultation with a medical toxicologist or clinical laboratory specialists with similar expertise increases the likelihood of substance detection (see <a class="local">'Toxicology testing'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Acute substance exposure – Children suspected of acute exposures should undergo urine drug screening with confirmation by advanced methods if initial screening is positive. Substances detected, time frame for detection after acute exposure, and potential causes of false positives on typical urine drugs of abuse screens are summarized in the table  (<a class="graphic graphic_table graphicRef95110" href="/z/d/graphic/95110.html" rel="external">table 8</a>). Based on history and regional illicit drug trends (eg, <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">fentanyl</a>, fentanyl analogs, cathinones, or synthetic cannabinoids), more comprehensive testing may be indicated. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Occult/chronic substance exposure – In addition to urine drugs of abuse testing, asymptomatic children with possible chronic exposures may warrant hair testing for forensic purposes performed by a laboratory experienced in toxicologic testing of alternative specimens.</p><p></p><p class="bulletIndent2">Careful interpretation of results considers the patient's clinical findings and detailed knowledge of the specific toxicologic testing that has been performed. Consultation with a medical toxicologist or clinical lab specialist with similar expertise is essential. Substance exposure needs to be differentiated from other reasons for positive results. (See <a class="local">'Interpretation of results'</a> above and <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reporting</strong> – Children suspected of substance exposure warrant urgent consultation with a social worker and, whenever available, involvement of a multidisciplinary child abuse team. In many jurisdictions, reporting substance exposure to child protective services and, if a separate report is required, law enforcement is also required. (See  <a class="medical medical_review" href="/z/d/html/6604.html" rel="external">"Child abuse: Social and medicolegal issues", section on 'Reporting suspected abuse'</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">National Alliance for Drug Endangered Children. https://www.nationaldec.org (Accessed on January 28, 2021).</li><li><a class="nounderline abstract_t">Graham J, Leonard J, Banerji S, Wang GS. Illicit Drug Exposures in Young Pediatric Patients Reported to the National Poison Data System, 2006-2016. J Pediatr 2020; 219:254.</a></li><li class="breakAll">Office of National Drug Control Policy. Drug Endangered Children. https://obamawhitehouse.archives.gov/ondcp/dec-info (Accessed on November 09, 2020).</li><li class="breakAll">Farst K, Wells K. Drug Endangered Children. In: Child Abuse Medical Diagnosis and Management, 4th edition, Laskey A, Sirotnak A (Eds), American Academy of Pediatrics, 2020.</li><li><a class="nounderline abstract_t">Wang X, Drummer OH. Review: Interpretation of drug presence in the hair of children. Forensic Sci Int 2015; 257:458.</a></li><li class="breakAll">Crane EH. Emergency Department Visits Involving the Accidental Ingestion of Opioid Pain Relievers by Children Aged 1 to 5. In: The CBHSQ Report, Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD 2017.</li><li><a class="nounderline abstract_t">Gaither JR, Leventhal JM, Ryan SA, Camenga DR. National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012. JAMA Pediatr 2016; 170:1195.</a></li><li><a class="nounderline abstract_t">Hilado MA, Getz A, Rosenthal R, Im DD. Fatal Transdermal Fentanyl Patch Overdose in a Child. Cureus 2020; 12:e6755.</a></li><li><a class="nounderline abstract_t">Messina N, Jeter K, Marinelli-Casey P, et al. Children exposed to methamphetamine use and manufacture. Child Abuse Negl 2014; 38:1872.</a></li><li class="breakAll">United States Department of Health &amp; Human Services, Administration for Children and Families, Administration on Children, Youth and Families, Children's Bureau. Child Maltreatment 2017. Available at https://www.acf.hhs.gov/cb/research-data-technology/statistics-research/child-maltreatment (Accessed on August 10, 2019).</li><li class="breakAll">Handle With Care. https://www.tnhandlewithcare.org (Accessed on June 03, 2021).</li><li class="breakAll">Colorado Office of Children, Youth &amp; Families, Division of Child Welfare. Toxicology resource guide. https://www.cotoxguide.org/ (Accessed on June 03, 2021).</li><li class="breakAll">Parental substance abuse as child abuse. https://www.childwelfare.gov/pubPDFs/parentalsubstanceuse.pdf (Accessed on November 09, 2020).</li><li class="breakAll">Lipari RN, Van Horn SL. Children living with parents who have a substance use disorder. The CBHSQ Report: August 24, 2017. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD. https://www.samhsa.gov/data/sites/default/files/report_3223/ShortReport-3223.html (Accessed on February 22, 2021).</li><li><a class="nounderline abstract_t">Bondi SA, Scibilia J, COMMITTEE ON MEDICAL LIABILITY AND RISK MANAGEMENT. Dealing With the Caretaker Whose Judgment Is Impaired by Alcohol or Drugs: Legal and Ethical Considerations. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Brook J, McDonald TP, Gregoire T, et al. Parental substance abuse and family reunification. J Soc Work Pract Addict 2010; 10:393.</a></li><li class="breakAll">Institute of Medicine and National Research Council (2013). New directions in child abuse and neglect research. Washington, DC: The National Academies Press. http://www.iom.edu/ Reports/2013/New-Directions-in-Child-Abuse-andNeglect-Research.aspx (Accessed on January 29, 2021).</li><li><a class="nounderline abstract_t">Petska HW, Porada K, Nugent M, et al. Occult drug exposure in young children evaluated for physical abuse: An opportunity for intervention. Child Abuse Negl 2019; 88:412.</a></li><li><a class="nounderline abstract_t">Oral R, Bayman L, Assad A, et al. Illicit drug exposure in patients evaluated for alleged child abuse and neglect. Pediatr Emerg Care 2011; 27:490.</a></li><li><a class="nounderline abstract_t">Stauffer SL, Wood SM, Krasowski MD. Diagnostic yield of hair and urine toxicology testing in potential child abuse cases. J Forensic Leg Med 2015; 33:61.</a></li><li><a class="nounderline abstract_t">Peleg-Oren N, Teichman M. Young children of parents with substance use disorders (SUD): A review of the literature and implications for social work practice. J Soc Work Pract Addict 2006; 6:49.</a></li><li class="breakAll">IOM (Institute of Medicine) and NRC (National Research Council (2014). New directions in child abuse and neglect research. Washington, DC: The National Academies Press.</li><li><a class="nounderline abstract_t">Deutsch SA, Donahue J, Parker T, et al. Factors Associated with Child-Welfare Involvement among Prenatally Substance-Exposed Infants. J Pediatr 2020; 222:35.</a></li><li><a class="nounderline abstract_t">Farst K, Bolden BB. Substance-Exposed Infants and Children: Forensic Approach. Clin Pediatr Emerg Med 2012; 13:221.</a></li><li><a class="nounderline abstract_t">Hayek SN, Wibbenmeyer LA, Kealey LD, et al. The efficacy of hair and urine toxicology screening on the detection of child abuse by burning. J Burn Care Res 2009; 30:587.</a></li><li><a class="nounderline abstract_t">Bond GR, Woodward RW, Ho M. The growing impact of pediatric pharmaceutical poisoning. J Pediatr 2012; 160:265.</a></li><li><a class="nounderline abstract_t">Farst K, Duncan JM, Moss M, et al. Methamphetamine exposure presenting as caustic ingestions in children. Ann Emerg Med 2007; 49:341.</a></li><li><a class="nounderline abstract_t">Burge M, Hunsaker JC 3rd, Davis GJ. Death of a toddler due to ingestion of sulfuric acid at a clandestine home methamphetamine laboratory. Forensic Sci Med Pathol 2009; 5:298.</a></li><li><a class="nounderline abstract_t">Grant P. Evaluation of children removed from a clandestine methamphetamine laboratory. J Emerg Nurs 2007; 33:31.</a></li><li><a class="nounderline abstract_t">Kelleher K, Chaffin M, Hollenberg J, Fischer E. Alcohol and drug disorders among physically abusive and neglectful parents in a community-based sample. Am J Public Health 1994; 84:1586.</a></li><li><a class="nounderline abstract_t">Wells K. Substance abuse and child maltreatment. Pediatr Clin North Am 2009; 56:345.</a></li><li><a class="nounderline abstract_t">Connell-Carrick K. Methamphetamine and the changing face of child welfare: practice principles for child welfare workers. Child Welfare 2007; 86:125.</a></li><li class="breakAll">Working with Medical Professionals in Drug Endangered Children (DEC) Efforts https://www.cossapresources.org/Content/Documents/Articles/National_DEC_Medical_Professional_One_Pager_2020.pdf (Accessed on August 05, 2022).</li><li><a class="nounderline abstract_t">Smith VC, Wilson CR, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Families Affected by Parental Substance Use. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Solis JM, Shadur JM, Burns AR, Hussong AM. Understanding the diverse needs of children whose parents abuse substances. Curr Drug Abuse Rev 2012; 5:135.</a></li><li class="breakAll">CHILD ABUSE AND NEGLECT USER MANUAL SERIES. Protecting children in families affected by substance use disorders. https://www.childwelfare.gov/pubPDFs/substanceuse.pdf (Accessed on June 03, 2021).</li><li><a class="nounderline abstract_t">Farst K, Reading Meyer JA, Mac Bird T, et al. Hair drug testing of children suspected of exposure to the manufacture of methamphetamine. J Forensic Leg Med 2011; 18:110.</a></li><li><a class="nounderline abstract_t">Howell S, Bailey L, Coffman J. Evaluation of drug-endangered children: The yield of toxicology and skeletal survey screening. Child Abuse Negl 2019; 96:104081.</a></li><li><a class="nounderline abstract_t">Wood JN, Pecker LH, Russo ME, et al. Evaluation and referral for child maltreatment in pediatric poisoning victims. Child Abuse Negl 2012; 36:362.</a></li><li><a class="nounderline abstract_t">Grant P, Bell K, Stewart D, et al. Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories. Pediatr Emerg Care 2010; 26:10.</a></li><li class="breakAll">Drug Testing in Child Welfare: Practice and Policy Considerations. https://ncsacw.samhsa.gov/files/drugtestinginchildwelfare.pdf (Accessed on January 29, 2021).</li><li><a class="nounderline abstract_t">Tessier W, Keegan W. Mandatory Blood Testing: When can police compel a health provider to draw a patient's blood to determine blood levels of alcohol or other intoxicants? Mo Med 2019; 116:274.</a></li><li><a class="nounderline abstract_t">Bornstein BH. Pregnancy, drug testing, and the fourth amendment: legal and behavioral implications. J Fam Psychol 2003; 17:220.</a></li><li><a class="nounderline abstract_t">Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc 2008; 83:66.</a></li><li><a class="nounderline abstract_t">Wang GS, Roosevelt G, Becker A, et al. Evaluation of drug use and medication compliance in adolescents admitted to a psychiatric facility from the pediatric emergency department. Gen Hosp Psychiatry 2017; 46:38.</a></li><li><a class="nounderline abstract_t">von Mach MA, Weber C, Meyer MR, et al. Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department. Ther Drug Monit 2007; 29:27.</a></li><li><a class="nounderline abstract_t">Kyle PB, Spencer JL, Purser CM, et al. Suspected pediatric ingestions: effectiveness of immunoassay screens vs. gas chromatography/mass spectroscopy in the detection of drugs and chemicals. J Toxicol Clin Toxicol 2003; 41:919.</a></li><li><a class="nounderline abstract_t">White RM. Drugs in hair. Part I. Metabolisms of major drug classes. Forensic Sci Rev 2017; 29:23.</a></li><li><a class="nounderline abstract_t">Petska HW, Budzak-Garza AE, Graff AH, et al. Advocating for Our Youngest Victims: Wisconsin's Approach to Testing Drug-Endangered Children. WMJ 2019; 118:109.</a></li><li><a class="nounderline abstract_t">Kintz P. Hair Analysis in Forensic Toxicology: An Updated Review with a Special Focus on Pitfalls. Curr Pharm Des 2017; 23:5480.</a></li><li><a class="nounderline abstract_t">Shukla RK, Bell K, Maier EA, Newton DC. Forensic evaluations of drug endangered children: “My house caught on fire; my cat jumped out the window”. Child Youth Serv Rev 2016; 67:67.</a></li></ol></div><div id="topicVersionRevision">Topic 130622 Version 5.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.nationaldec.org" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : National Alliance for Drug Endangered Children. https://www.nationaldec.org (Accessed on January 28, 2021).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31952846" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Illicit Drug Exposures in Young Pediatric Patients Reported to the National Poison Data System, 2006-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31952846" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Illicit Drug Exposures in Young Pediatric Patients Reported to the National Poison Data System, 2006-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31952846" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Illicit Drug Exposures in Young Pediatric Patients Reported to the National Poison Data System, 2006-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26610304" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Review: Interpretation of drug presence in the hair of children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26610304" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Review: Interpretation of drug presence in the hair of children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27802492" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32140323" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Fatal Transdermal Fentanyl Patch Overdose in a Child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17383002" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Children exposed to methamphetamine use and manufacture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17383002" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Children exposed to methamphetamine use and manufacture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17383002" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Children exposed to methamphetamine use and manufacture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17383002" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Children exposed to methamphetamine use and manufacture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17383002" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Children exposed to methamphetamine use and manufacture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17383002" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Children exposed to methamphetamine use and manufacture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31767716" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Dealing With the Caretaker Whose Judgment Is Impaired by Alcohol or Drugs: Legal and Ethical Considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Parental substance abuse and family reunification</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Parental substance abuse and family reunification</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30605795" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Occult drug exposure in young children evaluated for physical abuse: An opportunity for intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21629147" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Illicit drug exposure in patients evaluated for alleged child abuse and neglect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26048499" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Diagnostic yield of hair and urine toxicology testing in potential child abuse cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Young children of parents with substance use disorders (SUD): A review of the literature and implications for social work practice</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Young children of parents with substance use disorders (SUD): A review of the literature and implications for social work practice</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32418814" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Factors Associated with Child-Welfare Involvement among Prenatally Substance-Exposed Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Substance-Exposed Infants and Children: Forensic Approach</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19506505" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The efficacy of hair and urine toxicology screening on the detection of child abuse by burning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21920539" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The growing impact of pediatric pharmaceutical poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17141141" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Methamphetamine exposure presenting as caustic ingestions in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19936975" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Death of a toddler due to ingestion of sulfuric acid at a clandestine home methamphetamine laboratory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17258050" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Evaluation of children removed from a clandestine methamphetamine laboratory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7943475" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Alcohol and drug disorders among physically abusive and neglectful parents in a community-based sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19358920" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Substance abuse and child maltreatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17722684" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Methamphetamine and the changing face of child welfare: practice principles for child welfare workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17722684" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Methamphetamine and the changing face of child welfare: practice principles for child welfare workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27432847" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Families Affected by Parental Substance Use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22455509" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Understanding the diverse needs of children whose parents abuse substances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22455509" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Understanding the diverse needs of children whose parents abuse substances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21420647" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Hair drug testing of children suspected of exposure to the manufacture of methamphetamine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31344584" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Evaluation of drug-endangered children: The yield of toxicology and skeletal survey screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22571909" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Evaluation and referral for child maltreatment in pediatric poisoning victims.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20042914" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20042914" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31527966" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Mandatory Blood Testing: When can police compel a health provider to draw a patient's blood to determine blood levels of alcohol or other intoxicants?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12828018" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Pregnancy, drug testing, and the fourth amendment: legal and behavioral implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18174009" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Urine drug screening: practical guide for clinicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28622813" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Evaluation of drug use and medication compliance in adolescents admitted to a psychiatric facility from the pediatric emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17304147" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14705835" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Suspected pediatric ingestions: effectiveness of immunoassay screens vs. gas chromatography/mass spectroscopy in the detection of drugs and chemicals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28119266" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Drugs in hair. Part I. Metabolisms of major drug classes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31682744" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Advocating for Our Youngest Victims: Wisconsin's Approach to Testing Drug-Endangered Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28969544" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Hair Analysis in Forensic Toxicology: An Updated Review with a Special Focus on Pitfalls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Forensic evaluations of drug endangered children:“My house caught on fire; my cat jumped out the window”</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
